Biogen names top executive Vounatsos as CEO

(Reuters) - Biogen Inc, the U.S. drug maker focused on neurological, autoimmune and rare diseases, said on Monday it had appointed its chief commercial officer, Michel Vounatsos, as chief executive officer, ending a five-month search.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news